z-logo
open-access-imgOpen Access
Tafenoquine receives regulatory approval in USA for prophylaxis of malaria and radical cure of Plasmodium vivax
Author(s) -
Kathrine R. Tan,
Jimee Hwang
Publication year - 2018
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/tay071
Subject(s) - medicine , plasmodium vivax , malaria , malaria prophylaxis , primaquine , drug approval , intensive care medicine , plasmodium falciparum , immunology , pharmacology , chloroquine , drug

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom